BillionToOne, Inc. (BLLN) Technical Analysis & Indicators

BillionToOne, Inc. (BLLN) — Price $109.06 — Healthcare — Medical - Diagnostics & Research — NASDAQ

Latest reported results:

Technical analysis of BillionToOne, Inc. (BLLN): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.

BillionToOne, Inc. is a specialized diagnostics company that innovates by precisely quantifying biological data to create advanced molecular diagnostic solutions. Central to their operations is a cutting-edge molecular counting platform, meticulously engineered to identify and measure individual DNA molecules, thereby significantly enhancing the precision of disease detection.

Price Performance

1 month+9.73%
3 months-9.57%
Year-to-date+33.26%

52-Week Range

52-week High$150.44
52-week Low$61.96
Avg Volume (90d)719K

Technical Indicators

SMA 50$107.24
SMA 200$95.28
Beta-2.36
30-day Volatility (annualised)63.8%
Price vs SMA 50+1.7%
Price vs SMA 200+14.5%

Monthly Close (12 months)

MonthCloseChange
2025-11$130.18
2025-12$81.84-37.1%
2026-01$82.51+0.8%
2026-02$76.33-7.5%
2026-03$78.94+3.4%
2026-04$75.05-4.9%
2026-05$98.99+31.9%
2026-06$119.98+21.2%
2026-07$138.60+15.5%
2026-08$90.67-34.6%
2026-09$106.44+17.4%
2026-10$109.06+2.5%

Upcoming Earnings

DateEPS Est.Revenue Est.
2026-10-06$0.16$116M
2026-08-05$0.18$109M
2026-05-06$0.01$97M
2026-03-04$0.07$87M
2025-12-09$0.14$83M
2025-10-07$0.14$83M

Price

Price$109.06
Market Cap$5.0B
ExchangeNASDAQ
CountryUS

Valuation Ratios

P/E Ratio170.78
Price / Book9.15
EV / EBITDA88.89
Dividend Yield0.00%

Financial Health

Debt / Equity0.27
Current Ratio11.69

Explore sector: Healthcare · Medical - Diagnostics & Research

More sections of BLLN: Overview · Financials · Valuation · Statistics · Estimates · Ownership · News · Events

Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Investment Academy — learn to analyze stocks